VAM
GNMX
Verity Asset Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-30,500
| Closed | -$4K | – | 146 |
|
|
2019
Q4 | $4K | Buy |
30,500
+13,500
| +79% | +$1.77K | ﹤0.01% | 125 |
|
|
2019
Q3 | $3K | Hold |
17,000
| – | – | ﹤0.01% | 129 |
|
|
2019
Q2 | $3K | Hold |
17,000
| – | – | ﹤0.01% | 125 |
|
|
2019
Q1 | $3K | Hold |
17,000
| – | – | ﹤0.01% | 117 |
|
|
2018
Q4 | $12K | Buy |
17,000
+3,000
| +21% | +$2.12K | 0.02% | 104 |
|
|
2018
Q3 | $17K | Buy |
14,000
+2,500
| +22% | +$3.04K | 0.02% | 131 |
|
|
2018
Q2 | $13K | Buy |
11,500
+1,500
| +15% | +$1.7K | 0.01% | 113 |
|
|
2018
Q1 | $20K | Sell |
10,000
-4,500
| -31% | -$9K | 0.02% | 119 |
|
|
2017
Q4 | $28K | Buy |
+14,500
| New | +$28K | 0.02% | 129 |
|